Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01127971 · ClinicalTrials.gov registry record
Patient Registry: Partial Breast Irradiation
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 145
- Enrollment target
NCT01127971: Clinical Trial study, sponsored by Wake Forest University Health Sciences.
NCT01127971 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 145 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01127971 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 145 participants
- Enrollment target
Study Summary
This is an Aurora Health Care system registry of patients receiving accelerated partial breast irradiation and external beam.
Primary Outcome
The primary endpoint of this registry trial is collection and analysis of sufficient data to determine 5 and 10-year local recurrence rates for each PBI type used and for the overall Aurora population. The following endpoints will also be reported and analyzed: * Disease Free Survival * Regional Recurrence * Distant Metastasis * Combined Recurrence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-09 |
Why NCT01127971 stopped before completion
NCT01127971 is an observational study that tracks outcomes without assigning an intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01127971 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01127971 about?
NCT01127971 is a clinical study titled "Patient Registry: Partial Breast Irradiation". This is an Aurora Health Care system registry of patients receiving accelerated partial breast irradiation and external beam.
What is the current status of trial NCT01127971?
This trial is currently terminated. The enrollment target is 145 participants. The study started on 2010-02. Estimated completion is 2013-09.
Who is sponsoring clinical trial NCT01127971?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02688959 · 145 participants · NA
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
- NCT03586609 · 145 participants · Phase 2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- NCT03767595 · 145 participants · NA
ProACT Post-Approval Study
- NCT03808337 · 145 participants · Phase 2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia